Evolus EOLS
NASDAQ EOLS
$7.99 +0.03 (+0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Evolus (EOLS) Notes Payables (2017 - 2021)

Updated

Evolus (EOLS) posted Notes Payables of $19.95 million for Q3 2021, up 1.5% from the prior quarter.

Analysis

Evolus (EOLS) Notes Payables (2017 - 2021) Analysis & Trends

At the end of FY2020, Evolus' Notes Payables came in at $19.07 million.

  • Annual Notes Payables shows a three-year compound annual growth rate of -48.4% (FY2017 to FY2020).
  • In prior years, Evolus' Notes Payables was $138.69 million in FY2017.
  • The Q3 2021 figure stands as the highest quarterly Notes Payables since Q4 2017.
  • According to Business Quant data, Notes Payables for the three prior quarters was $19.65 million (Q2 2021), $19.35 million (Q1 2021) and $19.07 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Evolus 525.47 Mn 333.16 Mn 57.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 19.95 Mn
Jun 30, 2021 19.65 Mn
Mar 31, 2021 19.35 Mn
Dec 31, 2020 19.07 Mn
Dec 31, 2017 138.69 Mn
API Access

Evolus Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=EOLS&period=max&api_key=YOUR_API_KEY